Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:37 PM
NCT ID:
NCT04654351
Pre Assignment Details:
Participants with a diagnosis of hereditary angioedema (HAE) type I or II were enrolled in a single arm to receive TAK-667 single-dose per attack. Up to two additional injections were permitted per attack. Participants who subsequently experienced an acute attack continued to receive TAK-667 for up to a total of three eligible icatibant-treated attacks.
Recruitment Details:
Participants took part in the study at 2 investigative sites in Japan from 15 January 2021 to 27 July 2021.
Study:
NCT04654351
Study Brief:
Results Section:
NCT04654351